About LectinStars
Established in 2021, LectinStars Pharmaceuticals Ltd. was co-founded by Dr. Shie-Liang Hsieh, (MD. PhD) and Dr. Pei-Shan Sung (PhD) from the Genomics Research Center, Academia Sinica. "Science, Significance, Solution," representing our entrepreneurial spirit. Committed to addressing unmet medical needs, we specialize in the development of therapeutic antibodies and macromolecular drugs, aiming to bring significant benefits to society.
Innovative Research and Development, Inspiring a New Era for the Industry –
We're dedicated to innovating root-cause therapeutic drugs through advanced research and expertise, aiming to propel the biomedical pharmaceutical industry forward.
Exemplary Strategies, Elevating the Quality of Patient Life –
Grounded in a patient-centric approach, we wholeheartedly provide superior and tailored treatment strategies for those with medical needs. Through our efforts, we aspire to enhance the quality of healthcare experiences, promoting an improvement in their overall quality of life and fulfilling their expectations for better treatments.
Steadfast Cultivation, Collaborating for a Prosperous Future –
With diligence, we're committed to a sustainable foundation. Collaborating with talents, we aim for mutual prosperity, guided by scientific data, sharing results with shareholders, partners, and bringing tangible value to biomedicine and society.
Dr. Shie-Liang Hsieh is distinguished research fellow of the Genomics Research Center, Academia Sinica. He also holds a joint professorship at the Institute of Clinical Medicine, National Yang Ming Chiao Tung University, and serves as an adjunct professor at the Graduate Institute of Immunology, National Taiwan University College of Medicine.Specializing in innate immunity and glycomedicine, he explores pathogen-host interactions, particularly in triggering immune storm reactions. His groundbreaking discoveries have contributed to drug development for diseases like Dengue fever, Systemic lupus erythematosus (SLE), and Chronic Hepatitis B. Widely recognized in academia, Dr. Hsieh has published highly acclaimed papers in prestigious journals such as Nature, Nature Communications, and The Journal of Clinical Investigation, highlighting his significant impact.
Co-founder
Dr. Pei-Shan Sung specializes in immune modulation research related to extracellular vesicles. Her doctoral dissertation, " Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2" received the29th Outstanding Paper Award, Wang Ming-Ning Memorial foundation, and F1000 Recommended honor. The renowned journal "Trend in Immunology" also featured a dedicated spotlight article on her research. Dr. Sung's dissertation gained immediate attention, and her impactful research has been published in prestigious journals, including Nature Communications, The Journal of Clinical Investigation, Journal of Biomedical Science, and JCI Insight. Her exceptional contributions have solidified her as a rising star in both academia and industry.
Scientific advisor
Scientific advisor
Director of Department of Internal Medicine,
Chang Gung Memorial Hospital, Linkou
Scientific advisor
